Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Angiogenesis Inhibitors × Clear all

NCT06475755 2024-06-26

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT03461185 2018-03-09

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung